12-6526329-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014865.4(NCAPD2):c.2524G>A(p.Glu842Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000681 in 1,614,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014865.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPD2 | NM_014865.4 | c.2524G>A | p.Glu842Lys | missense_variant | 20/32 | ENST00000315579.10 | NP_055680.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPD2 | ENST00000315579.10 | c.2524G>A | p.Glu842Lys | missense_variant | 20/32 | 1 | NM_014865.4 | ENSP00000325017 | P1 | |
NCAPD2 | ENST00000382457.8 | c.2140G>A | p.Glu714Lys | missense_variant | 17/21 | 5 | ENSP00000371895 | |||
NCAPD2 | ENST00000542492.1 | n.457G>A | non_coding_transcript_exon_variant | 4/8 | 5 | |||||
NCAPD2 | ENST00000539084.5 | c.*2219G>A | 3_prime_UTR_variant, NMD_transcript_variant | 19/31 | 2 | ENSP00000438495 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251490Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135920
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461892Hom.: 0 Cov.: 42 AF XY: 0.00000825 AC XY: 6AN XY: 727248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74440
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.2524G>A (p.E842K) alteration is located in exon 20 (coding exon 19) of the NCAPD2 gene. This alteration results from a G to A substitution at nucleotide position 2524, causing the glutamic acid (E) at amino acid position 842 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at